Cargando…

HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure

BACKGROUND: Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Ryo, Nishiyama, Osamu, Yoshikawa, Kazuya, Saeki, Sho, Sano, Hiroyuki, Iwanaga, Takashi, Tohda, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822325/
https://www.ncbi.nlm.nih.gov/pubmed/33481923
http://dx.doi.org/10.1371/journal.pone.0245778
_version_ 1783639608764923904
author Yamazaki, Ryo
Nishiyama, Osamu
Yoshikawa, Kazuya
Saeki, Sho
Sano, Hiroyuki
Iwanaga, Takashi
Tohda, Yuji
author_facet Yamazaki, Ryo
Nishiyama, Osamu
Yoshikawa, Kazuya
Saeki, Sho
Sano, Hiroyuki
Iwanaga, Takashi
Tohda, Yuji
author_sort Yamazaki, Ryo
collection PubMed
description BACKGROUND: Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the clinical features and outcomes of patients with IPF who required nonelective hospitalization because of HF. METHODS: We examined data from IPF patients who required nonelective hospitalization for HF at the Kindai University Hospital from January 2008 to December 2018. We divided the patients into 3 groups: those with HFpEF without elevated right ventricular systolic pressure (RVSP), those with HFpEF and elevated RVSP, and those with HFrEF. The recurrence rates of HF after discharge and the 30- and 90-day mortality rates of the patients were evaluated. RESULTS: During the study period, 37 patients with IPF required hospitalization because of HF. Among the 34 patients included in the study, 17 (50.0%) were diagnosed with HFpEF without elevated RVSP, 11 (32.3%) with HFpEF and elevated RVSP, and 6 (17.6%) with HFrEF. Patients with HFrEF had significantly higher values for B-type natriuretic peptide (BNP) and left ventricular (LV) end-systolic and end-diastolic diameters than patients with the 2 types of HFpEF (BNP: P = 0.01 and P = 0.0004, LV end-systolic diameter: P <0.0001 and P <0.0001, and LV end-diastolic diameter: P = 0.01 and P = 0.0004, respectively). Notably, the difference between the LVEFs of the patients with 2 types of HFpEF was not significant. The patients with HFpEF without elevated RVSP had the lowest 30- and 90-day mortality rates (0%, P = 0.02 and 11.7%, P = 0.11, respectively). CONCLUSIONS: Among patients with IPF, HFpEF without elevated RVSP was the most common type of HF that required hospitalization. Patients with HFpEF without elevated RVSP survived longer than the patients with the other 2 types of HF.
format Online
Article
Text
id pubmed-7822325
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78223252021-01-29 HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure Yamazaki, Ryo Nishiyama, Osamu Yoshikawa, Kazuya Saeki, Sho Sano, Hiroyuki Iwanaga, Takashi Tohda, Yuji PLoS One Research Article BACKGROUND: Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the clinical features and outcomes of patients with IPF who required nonelective hospitalization because of HF. METHODS: We examined data from IPF patients who required nonelective hospitalization for HF at the Kindai University Hospital from January 2008 to December 2018. We divided the patients into 3 groups: those with HFpEF without elevated right ventricular systolic pressure (RVSP), those with HFpEF and elevated RVSP, and those with HFrEF. The recurrence rates of HF after discharge and the 30- and 90-day mortality rates of the patients were evaluated. RESULTS: During the study period, 37 patients with IPF required hospitalization because of HF. Among the 34 patients included in the study, 17 (50.0%) were diagnosed with HFpEF without elevated RVSP, 11 (32.3%) with HFpEF and elevated RVSP, and 6 (17.6%) with HFrEF. Patients with HFrEF had significantly higher values for B-type natriuretic peptide (BNP) and left ventricular (LV) end-systolic and end-diastolic diameters than patients with the 2 types of HFpEF (BNP: P = 0.01 and P = 0.0004, LV end-systolic diameter: P <0.0001 and P <0.0001, and LV end-diastolic diameter: P = 0.01 and P = 0.0004, respectively). Notably, the difference between the LVEFs of the patients with 2 types of HFpEF was not significant. The patients with HFpEF without elevated RVSP had the lowest 30- and 90-day mortality rates (0%, P = 0.02 and 11.7%, P = 0.11, respectively). CONCLUSIONS: Among patients with IPF, HFpEF without elevated RVSP was the most common type of HF that required hospitalization. Patients with HFpEF without elevated RVSP survived longer than the patients with the other 2 types of HF. Public Library of Science 2021-01-22 /pmc/articles/PMC7822325/ /pubmed/33481923 http://dx.doi.org/10.1371/journal.pone.0245778 Text en © 2021 Yamazaki et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yamazaki, Ryo
Nishiyama, Osamu
Yoshikawa, Kazuya
Saeki, Sho
Sano, Hiroyuki
Iwanaga, Takashi
Tohda, Yuji
HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
title HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
title_full HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
title_fullStr HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
title_full_unstemmed HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
title_short HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure
title_sort hfpef without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with ipf requiring hospitalization for heart failure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822325/
https://www.ncbi.nlm.nih.gov/pubmed/33481923
http://dx.doi.org/10.1371/journal.pone.0245778
work_keys_str_mv AT yamazakiryo hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure
AT nishiyamaosamu hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure
AT yoshikawakazuya hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure
AT saekisho hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure
AT sanohiroyuki hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure
AT iwanagatakashi hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure
AT tohdayuji hfpefwithoutelevatedrightventricularsystolicpressureisafavorableprognosticindicatorinpatientswithipfrequiringhospitalizationforheartfailure